1. Pink Sheet
  2. >>Agency Leadership
  3. >>US FDA

What Might FDA Do Post Roe? Eliminate Mifepristone REMS

 
• By Brenda Sandburg

Attorneys say the biggest step FDA could take to expand access to medication abortion would be to eliminate REMS requirement for mifepristone. Timeline notes steps Biden administration and Congress have taken since the Supreme Court’s ruling overturning the right to an abortion.

Medication abortion
Biden Administration is considering ways to increase access to the medication abortion pill mifepristone • Source: Shutterstock

The US Department of Health and Human Services is expected to issue a report soon noting what the administration can do to expand access to medication abortion. Attorneys point to one action the US Food and Drug Administration could take to accomplish this goal: eliminate the Risk Evaluation and Mitigation Strategy for mifepristone.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from US FDA

More from Agency Leadership